Introduction:

HIV co-infection with hepatitis B or C is the cause of chronic liver disease, with various seropre- valences in different regions of the world.

Objective:

To know the seroprevalence of hepatitis B and C in people with HIV who come for consultation at the Institute for Human Development, Cochabamba-Bolivia, management 2017-2018.

Materials and methods:

Descriptive, prospective-cross-sectional, quantitative, non-experimental study. The serological results of the markers were analyzed: Hepatitis B virus surface antigen, Hepatitis B virus anti-core antibody, Hepatitis C virus antibody; Hepatitis B vaccine history and antiretroviral treatment scheme of 195 people with HIV at the Institute for Human Development, bivariate analysis was performed to obtain data.

Results:

The seroprevalence obtained for hepatitis B is 7.7% and hepatitis C 0.5%; coinfection between HIV and hepatitis B is 80% with the antiretroviral regimen tenofovir / lamivudine. The homosexual population group has a 5.5 times risk of having HIV and hepatitis B co-infection with a p value of 0.006; Regarding immunization for hepatitis B, only 9.2% of patients have the complete scheme.

Conclusion:

It is imperative to offer hepatitis B and C testing to all people with HIV; emphasizing the most vulnerable groups (homosexuals); The provision of doses for complete immunization against hepatitis B in all public health services in the country is important.